Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP)

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.102258Source: DataRank Database

Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP) is a research paper published in Clinical Genitourinary Cancer (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.10)OA: greenTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Rajvi Goradia ORCID,Victor Heh,Akshay Sood ORCID,Matthew Lee ORCID,Young Son ORCID

Live enrichment

PubMed:39615117 PMC:PMC11757078 OpenAlex:https://openalex.org/W4403977911

National Institutes of Health

Grant: 2P30CA016058-45

Cancer Center Support Grant

NCI NIH HHS

Grant: K12 CA133250

NCI NIH HHS

Grant: K12 CA132783

NCI NIH HHS

Grant: P30 CA016058

FWCI

1.10

Citation Percentile

0.8%

Citation Trend

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11757078/

publisherhttps://api.elsevier.com/content/article/PII:S1558767324002283?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1558767324002283?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.clgc.2024.102258

Fields of Study

Renal cell carcinoma treatmentPancreatic and Hepatic Oncology ResearchBladder and Urothelial Cancer Treatments03 medical and health sciences0302 clinical medicineHumansCytoreduction Surgical ProceduresKidney NeoplasmsMaleFemaleNephrectomyCarcinoma, Renal CellMiddle AgedQuality ImprovementAgedPostoperative ComplicationsTreatment OutcomeRetrospective StudiesPreoperative Care

MeSH Terms

AgedCarcinoma, Renal CellFemaleHumansKidney NeoplasmsMaleMiddle AgedNephrectomyPostoperative ComplicationsPreoperative CareRetrospective StudiesTreatment OutcomeNeoadjuvant TherapyQuality ImprovementCytoreduction Surgical Procedures

Keywords

MedicineSystemic therapyNephrectomyCytoreductive surgerySurgeryCancerInternal medicineKidneyBreast cancerClinical TrialsMetastatic Renal Cell CarcinomaSurgical ComplicationsPerioperative OutcomesImmune Checkpoint InhibitorsMaleCytoreduction Surgical ProceduresMiddle AgedQuality ImprovementArticleKidney NeoplasmsPostoperative ComplicationsTreatment OutcomePreoperative CareHumansFemaleCarcinoma, Renal CellAgedRetrospective Studies